Asia’s private secondaries market at 'early stage': Jefferies Chinese transactions are benefitting from a booming IPO market in Hong Kong, which is driving Asia growth from a low base. January 27, 2026
Fosun IPO set to broaden Hong Kong equity markets Acquisitive conglomerate launches an IPO for Israel-based Sisram Medical, a company it acquired four years ago during the early stage of China’s overseas M&A boom. August 31, 2017
NTPC sale powers up India divestment ambitions India kicks off one of the largest ever government divestment deals with a $2.2 billion sale of shares in the country’s largest power producer. August 29, 2017
India's BSE launches landmark IPO Asia’s oldest exchange moves ahead with its listing plan, a move seen as crucial as India creates a developed equities market. NSE could be next. January 22, 2017
Sherry Liu cut as Jefferies axe falls again The redundancies, which also included Ren Wang, are part of a wider restructuring away from chasing low-fee SOE restructuring deals. December 22, 2015
Biocon opens book for Syngene IPO Indian pharma company spins off contract research arm, hoping markets will regain a solid footing after Monday's sharp fall. July 27, 2015
Four more leave Jefferies in Hong Kong The HK office continues to lose bankers with four more, including head of corporate finance for Asia Ronald Tam, leaving the firm. July 24, 2015
MUFG poaches Augusto King from Jefferies King joins as Asia-Pacific capital markets head as the Japanese firm expands footprint in Asia. Brings in former RBS colleague Kennis Wong. June 24, 2015
Syngene tests investor appetite for IPO Parent Biocon hopes the CRO's strong growth profile and expansion plans will mitigate recent downturn in the Indian equity market May 15, 2015
Three investment bankers leave Jefferies Two managing directors Richard Yang and Dai Qiang and a senior vice president Terry Zhi are vacating the firm. March 31, 2015